Site icon Oruen

The efficacy of Apomorphine – A non-motor perspective: Prof. K Ray Chaudhuri

Screenshot 2021 11 18 At 17.05.13

Screenshot 2021 11 18 At 17.05.13

Professor K Ray Chaudhuri MD, DSc, FRCP, FEAN, Professor of Movement Disorders and Neurology at King’s College Hospital, London, England.

In this video, Prof. Chaudhuri answers the following questions:

Would you say that Parkinson’s disease is more than just a movement disorder?

Which therapeutic options do you see to manage the previously mentioned non-kotor aspects

Where do you see its beneficial effect on non-motor symptoms?

How do you see the dopamine agonist phobia in Parkinson’s treatment?

When does it matter? What is your opinion here, especially on Apomorphine?

This interview was supported by EVER Pharma

 

 

Exit mobile version